Andrew Cheng

Andrew Cheng

Chief Executive Officer at AKERO THERAPEUTICS, INC.

Net worth: 16 M $ as of 30/03/2024

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Andrew Cheng is currently the President, Chief Executive Officer & Director at Akero Therapeutics, Inc., a Non-Executive Director at MorphoSys AG, an Independent Director at Vera Therapeutics, Inc., and a Director at Boys & Girls Clubs of Metro Los Angeles.
He previously served as an Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022, and held positions as a Director at Syntimmune, Inc., a Director at Global Virus Network, and the Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. from 1999 to 2018.
Dr. Cheng received his undergraduate degree from The Johns Hopkins University in 1988 and his doctorate from Columbia University College of Physicians & Surgeons in 1996.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/03/2024 589,447 ( 0.85% ) 15 M $ 30/03/2024
17/03/2024 17,488 ( 0.03% ) 754 083 $ 30/03/2024

Andrew Cheng active positions

CompaniesPositionStart
AKERO THERAPEUTICS, INC. Chief Executive Officer 31/08/2018
VERA THERAPEUTICS, INC. Director/Board Member 30/04/2017
MORPHOSYS AG Director/Board Member 17/05/2022
Director/Board Member -
All active positions of Andrew Cheng

Former positions of Andrew Cheng

CompaniesPositionEnd
ARBUTUS BIOPHARMA CORPORATION Director/Board Member 24/05/2022
GILEAD SCIENCES, INC. Chief Tech/Sci/R&D Officer 06/09/2018
Director/Board Member -
Director/Board Member -
See the detail of Andrew Cheng's experience

Training of Andrew Cheng

The Johns Hopkins University Undergraduate Degree
Columbia University College of Physicians & Surgeons Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Cheng's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
GILEAD SCIENCES, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

MORPHOSYS AG

Health Technology

AKERO THERAPEUTICS, INC.

Health Technology

VERA THERAPEUTICS, INC.

Health Technology

Private companies3

Health Technology

Commercial Services

Commercial Services

See company connections